Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.579 | 0.654 | 1.00 |
|
disease | 0.850 | None | 1.000 | 3 | 0 | 2008 | 2018 | ||||||||
|
tryptophan hydroxylase 2 | 0.546 | 0.654 | 2.5E-07 |
|
disease | 0.800 | None | 0.800 | 5 | 0 | 2004 | 2019 | ||||||||
|
dopamine receptor D2 | 0.436 | 0.846 | 0.75 |
|
disease | 0.800 | None | 1.000 | 5 | 0 | 1993 | 2019 | ||||||||
|
DISC1 scaffold protein | 0.548 | 0.769 | 1.7E-06 |
|
disease | 0.800 | None | 1.000 | 5 | 0 | 2006 | 2018 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.800 | None | 0.600 | 5 | 0 | 1997 | 2018 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.740 | None | 1.000 | 5 | 0 | 1992 | 2013 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
disease | 0.740 | None | 1.000 | 4 | 0 | 2004 | 2017 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.720 | None | 1.000 | 2 | 0 | 2003 | 2017 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1994 | 2019 | ||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1991 | 2019 | |||||||||
|
catechol-O-methyltransferase | 0.400 | 0.923 | 1.1E-06 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1997 | 2019 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1991 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.700 | None | 0.800 | 5 | 0 | 2004 | 2017 | ||||||||
|
ankyrin 3 | 0.578 | 0.654 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 2008 | 2020 | ||||||||
|
5-hydroxytryptamine receptor 2A | 0.473 | 0.846 | 0.51 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1999 | 2014 | ||||||||
|
CUB and Sushi multiple domains 1 | 0.610 | 0.500 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 2011 | 2020 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 1997 | 2020 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.700 | None | 0.800 | 5 | 0 | 2008 | 2020 | ||||||||
|
calcium voltage-gated channel subunit alpha1 C | 0.510 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 5 | 0 | 2010 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 7 subunit | 0.532 | 0.654 | 4.2E-04 |
|
disease | 0.700 | None | 0.750 | 4 | 0 | 1998 | 2019 | ||||||||
|
serine racemase | 0.617 | 0.692 | 5.8E-03 |
|
disease | 0.700 | None | 0.750 | 4 | 0 | 2005 | 2019 | ||||||||
|
transcription factor 4 | 0.464 | 0.846 | 1.00 |
|
disease | 0.700 | None | 1.000 | 4 | 0 | 1999 | 2019 | ||||||||
|
neurocan | 0.670 | 0.500 | 6.8E-02 |
|
disease | 0.680 | None | 1.000 | 5 | 0 | 2011 | 2019 | ||||||||
|
SET domain containing 1A, histone lysine methyltransferase | 0.619 | 0.615 | 1.00 |
|
disease | 0.650 | moderate | 1.000 | 1 | 0 | 2014 | 2019 | ||||||||
|
Sp4 transcription factor | 0.711 | 0.423 | 0.99 |
|
disease | 0.630 | None | 1.000 | 2 | 0 | 2009 | 2019 |